Genetic analysis of a pediatric clinical isolate of moraxella catarrhalis with resistance to macrolides and quinolones

Satoshi Iwata, Yoshitake Sato, Yoshikiyo Toyonaga, Hideaki Hanaki, Keisuke Sunakawa

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

During the surveillance conducted in 2012 by the Drug-resistant Pathogen Surveillance Group in Pediatric Infectious Disease, we isolated a strain of Moraxella catarrhalis that demonstrated resistance to both macrolides and quinolones from a male pediatric patient aged 1.5 years who had developed acute bronchitis. Then we evaluated the susceptibility of this strain to different types of antibacterial agents and conducted a genetic analysis. The results of the susceptibility evaluation showed that the MIC values of azithromycin, clarithromycin, and rokitamycin were >64μg/mL, >64μg/mL, and 4μg/mL, respectively; clearly demonstrating resistance to macrolides. The MIC values of the quinolones levofloxacin, tosufloxacin, and garenoxacin were 4μg/mL, 2μg/mL, and 1μg/mL, respectively; indicating decreased susceptibility. The genetic analysis of this strain revealed one mutation in 23s rRNA with a replacement of adenine by thymine at nucleotide position 2330 (A2330T) and another mutation in gyrB at nucleotide position 1481 by replacement of adenine with guanine (A1481G) that caused a substitution of the 494th asparagine acid by glycine, as being associated with the observed resistance to macrolides and quinolones, respectively. Similar to drug-resistant bacteria Streptococcus pneumoniae and Haemophilus influenzae, the prevalence of which has recently increased, the treatment of drug-resistant M. catarrhalis infections is considered difficult due to the development of resistance to different types of antibacterial agents. It is vital to maintain an unwavering focus on the trend toward an increasing number of drug-resistant M. catarrhalis strains and ensure the proper use of each antibacterial agent.

Original languageEnglish
Pages (from-to)308-311
Number of pages4
JournalJournal of Infection and Chemotherapy
Volume21
Issue number4
DOIs
Publication statusPublished - 2015 Apr 1

Fingerprint

Moraxella (Branhamella) catarrhalis
Quinolones
Macrolides
Pediatrics
Adenine
tosufloxacin
Anti-Bacterial Agents
Pharmaceutical Preparations
Moraxellaceae Infections
Thymine Nucleotides
Levofloxacin
Mutation
Azithromycin
Clarithromycin
Bronchitis
Asparagine
Haemophilus influenzae
Guanine
Streptococcus pneumoniae
Glycine

Keywords

  • Drug resistance
  • Macrolides
  • Moraxella catarrhalis
  • Pediatric infectious disease
  • Quinolones
  • Susceptibility

ASJC Scopus subject areas

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

Genetic analysis of a pediatric clinical isolate of moraxella catarrhalis with resistance to macrolides and quinolones. / Iwata, Satoshi; Sato, Yoshitake; Toyonaga, Yoshikiyo; Hanaki, Hideaki; Sunakawa, Keisuke.

In: Journal of Infection and Chemotherapy, Vol. 21, No. 4, 01.04.2015, p. 308-311.

Research output: Contribution to journalArticle

Iwata, Satoshi ; Sato, Yoshitake ; Toyonaga, Yoshikiyo ; Hanaki, Hideaki ; Sunakawa, Keisuke. / Genetic analysis of a pediatric clinical isolate of moraxella catarrhalis with resistance to macrolides and quinolones. In: Journal of Infection and Chemotherapy. 2015 ; Vol. 21, No. 4. pp. 308-311.
@article{668fca0512aa4e058cc4a7cf55c040e3,
title = "Genetic analysis of a pediatric clinical isolate of moraxella catarrhalis with resistance to macrolides and quinolones",
abstract = "During the surveillance conducted in 2012 by the Drug-resistant Pathogen Surveillance Group in Pediatric Infectious Disease, we isolated a strain of Moraxella catarrhalis that demonstrated resistance to both macrolides and quinolones from a male pediatric patient aged 1.5 years who had developed acute bronchitis. Then we evaluated the susceptibility of this strain to different types of antibacterial agents and conducted a genetic analysis. The results of the susceptibility evaluation showed that the MIC values of azithromycin, clarithromycin, and rokitamycin were >64μg/mL, >64μg/mL, and 4μg/mL, respectively; clearly demonstrating resistance to macrolides. The MIC values of the quinolones levofloxacin, tosufloxacin, and garenoxacin were 4μg/mL, 2μg/mL, and 1μg/mL, respectively; indicating decreased susceptibility. The genetic analysis of this strain revealed one mutation in 23s rRNA with a replacement of adenine by thymine at nucleotide position 2330 (A2330T) and another mutation in gyrB at nucleotide position 1481 by replacement of adenine with guanine (A1481G) that caused a substitution of the 494th asparagine acid by glycine, as being associated with the observed resistance to macrolides and quinolones, respectively. Similar to drug-resistant bacteria Streptococcus pneumoniae and Haemophilus influenzae, the prevalence of which has recently increased, the treatment of drug-resistant M. catarrhalis infections is considered difficult due to the development of resistance to different types of antibacterial agents. It is vital to maintain an unwavering focus on the trend toward an increasing number of drug-resistant M. catarrhalis strains and ensure the proper use of each antibacterial agent.",
keywords = "Drug resistance, Macrolides, Moraxella catarrhalis, Pediatric infectious disease, Quinolones, Susceptibility",
author = "Satoshi Iwata and Yoshitake Sato and Yoshikiyo Toyonaga and Hideaki Hanaki and Keisuke Sunakawa",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.jiac.2014.11.002",
language = "English",
volume = "21",
pages = "308--311",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Genetic analysis of a pediatric clinical isolate of moraxella catarrhalis with resistance to macrolides and quinolones

AU - Iwata, Satoshi

AU - Sato, Yoshitake

AU - Toyonaga, Yoshikiyo

AU - Hanaki, Hideaki

AU - Sunakawa, Keisuke

PY - 2015/4/1

Y1 - 2015/4/1

N2 - During the surveillance conducted in 2012 by the Drug-resistant Pathogen Surveillance Group in Pediatric Infectious Disease, we isolated a strain of Moraxella catarrhalis that demonstrated resistance to both macrolides and quinolones from a male pediatric patient aged 1.5 years who had developed acute bronchitis. Then we evaluated the susceptibility of this strain to different types of antibacterial agents and conducted a genetic analysis. The results of the susceptibility evaluation showed that the MIC values of azithromycin, clarithromycin, and rokitamycin were >64μg/mL, >64μg/mL, and 4μg/mL, respectively; clearly demonstrating resistance to macrolides. The MIC values of the quinolones levofloxacin, tosufloxacin, and garenoxacin were 4μg/mL, 2μg/mL, and 1μg/mL, respectively; indicating decreased susceptibility. The genetic analysis of this strain revealed one mutation in 23s rRNA with a replacement of adenine by thymine at nucleotide position 2330 (A2330T) and another mutation in gyrB at nucleotide position 1481 by replacement of adenine with guanine (A1481G) that caused a substitution of the 494th asparagine acid by glycine, as being associated with the observed resistance to macrolides and quinolones, respectively. Similar to drug-resistant bacteria Streptococcus pneumoniae and Haemophilus influenzae, the prevalence of which has recently increased, the treatment of drug-resistant M. catarrhalis infections is considered difficult due to the development of resistance to different types of antibacterial agents. It is vital to maintain an unwavering focus on the trend toward an increasing number of drug-resistant M. catarrhalis strains and ensure the proper use of each antibacterial agent.

AB - During the surveillance conducted in 2012 by the Drug-resistant Pathogen Surveillance Group in Pediatric Infectious Disease, we isolated a strain of Moraxella catarrhalis that demonstrated resistance to both macrolides and quinolones from a male pediatric patient aged 1.5 years who had developed acute bronchitis. Then we evaluated the susceptibility of this strain to different types of antibacterial agents and conducted a genetic analysis. The results of the susceptibility evaluation showed that the MIC values of azithromycin, clarithromycin, and rokitamycin were >64μg/mL, >64μg/mL, and 4μg/mL, respectively; clearly demonstrating resistance to macrolides. The MIC values of the quinolones levofloxacin, tosufloxacin, and garenoxacin were 4μg/mL, 2μg/mL, and 1μg/mL, respectively; indicating decreased susceptibility. The genetic analysis of this strain revealed one mutation in 23s rRNA with a replacement of adenine by thymine at nucleotide position 2330 (A2330T) and another mutation in gyrB at nucleotide position 1481 by replacement of adenine with guanine (A1481G) that caused a substitution of the 494th asparagine acid by glycine, as being associated with the observed resistance to macrolides and quinolones, respectively. Similar to drug-resistant bacteria Streptococcus pneumoniae and Haemophilus influenzae, the prevalence of which has recently increased, the treatment of drug-resistant M. catarrhalis infections is considered difficult due to the development of resistance to different types of antibacterial agents. It is vital to maintain an unwavering focus on the trend toward an increasing number of drug-resistant M. catarrhalis strains and ensure the proper use of each antibacterial agent.

KW - Drug resistance

KW - Macrolides

KW - Moraxella catarrhalis

KW - Pediatric infectious disease

KW - Quinolones

KW - Susceptibility

UR - http://www.scopus.com/inward/record.url?scp=84931265170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84931265170&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2014.11.002

DO - 10.1016/j.jiac.2014.11.002

M3 - Article

C2 - 25481761

AN - SCOPUS:84931265170

VL - 21

SP - 308

EP - 311

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 4

ER -